Sun to fully acquire Caraco and take it private
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries is acquiring all outstanding shares of its US arm, Caraco Pharmaceutical Laboratories, as part of a merger agreement aimed at taking Caraco private.